Literature DB >> 10882051

Over-the-counter hearing aids: electroacoustic characteristics and possible target client groups.

C M Cheng1, B McPherson.   

Abstract

Over-the-counter hearing aids (OTCs) are those directly purchased from retail outlets, without the benefit of prior professional hearing health care. They are particularly common in developing countries. This study examined the amplification characteristics of a selected sample of OTCs to determine if any target client group or groups were suitable for the OTCs. The electroacoustical performance of 10 OTCs was measured. The measurements included saturated sound pressure level curve, high-frequency average full-on gain, frequency response, total harmonic distortion, equivalent input noise level, and input-output curve. The full-on gain curve of each hearing aid was used to estimate the hypothetical hearing loss of target clients for each aid as it would be calculated by four hearing aid prescription formulae. Real-ear probe tube measurements were also performed on 10 adult subjects to determine the amplification that could be achieved by the OTCs before audible feedback occurred. The OTC hearing aids were not able to meet the prescription gain requirements of the majority of elderly clients who usually purchased them.

Entities:  

Mesh:

Year:  2000        PMID: 10882051     DOI: 10.3109/00206090009073062

Source DB:  PubMed          Journal:  Audiology        ISSN: 0020-6091


  15 in total

Review 1.  Pilot Comparison of Adjustment Protocols of Personal Sound Amplification Products.

Authors:  Nicholas S Reed; Antoinette Oliver; Nirmal Kumar Srinivasan; Frank R Lin; Peggy A Korczak
Journal:  Semin Hear       Date:  2019-02-05

Review 2.  Argumentum ad Ignorantiam: Smartphone-Connected Listening Devices.

Authors:  David W Maidment; Amyn M Amlani
Journal:  Semin Hear       Date:  2020-12-16

3.  Pilot Electroacoustic Analyses of a Sample of Direct-to-Consumer Amplification Products.

Authors:  Nicholas S Reed; Joshua Betz; Frank R Lin; Sara K Mamo
Journal:  Otol Neurotol       Date:  2017-07       Impact factor: 2.311

Review 4.  Disruptive Hearing Technologies and Mild Sensorineural Hearing Loss II: Current Research on Affordable Hearing Technologies and Direct-to-Consumer Models.

Authors:  Anna Marie Jilla; Carole E Johnson; Jeffrey L Danhauer
Journal:  Semin Hear       Date:  2018-06-15

5.  Clinical Performance Evaluation of a Personal Sound Amplification Product vs a Basic Hearing Aid and a Premium Hearing Aid.

Authors:  Young Sang Cho; Su Yeon Park; Hye Yoon Seol; Ji Hyun Lim; Yang-Sun Cho; Sung Hwa Hong; Il Joon Moon
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2019-06-01       Impact factor: 6.223

Review 6.  Personal Sound Amplifiers for Adults with Hearing Loss.

Authors:  Sara K Mamo; Nicholas S Reed; Carrie L Nieman; Esther S Oh; Frank R Lin
Journal:  Am J Med       Date:  2015-10-21       Impact factor: 4.965

7.  Common Configurations of Real-Ear Aided Response Targets Prescribed by NAL-NL2 for Older Adults With Mild-to-Moderate Hearing Loss.

Authors:  Justin Jensen; Dhruv Vyas; Dana Urbanski; Harinath Garudadri; Octav Chipara; Yu-Hsiang Wu
Journal:  Am J Audiol       Date:  2020-07-21       Impact factor: 1.493

8.  Clinical evaluation of an over-the-counter hearing aid (TEO First®) in elderly patients suffering of mild to moderate hearing loss.

Authors:  Guillaume Sacco; Sébastien Gonfrier; Bernard Teboul; Ivan Gahide; Fredéric Prate; Mathilde Demory-Zory; Jean-Michel Turpin; Claire Vuagnoux; Philippe Genovese; Stéphane Schneider; Olivier Guérin; Nicolas Guevara
Journal:  BMC Geriatr       Date:  2016-07-09       Impact factor: 3.921

Review 9.  Applications of direct-to-consumer hearing devices for adults with hearing loss: a review.

Authors:  Vinaya Manchaiah; Brian Taylor; Ashley L Dockens; Nicole R Tran; Kayla Lane; Mariana Castle; Vibhu Grover
Journal:  Clin Interv Aging       Date:  2017-05-18       Impact factor: 4.458

10.  Over-the-Counter Hearing Aids: A Lost Decade for Change.

Authors:  Zoe Yee Ting Chan; Bradley McPherson
Journal:  Biomed Res Int       Date:  2015-10-18       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.